Supplement for Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial

Supplementary data pertaining to “Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial” by J. Rousel, et al. (2023), published in the Journal of the American Academy of Dermatology.本补充数据对应由J. Rousel等人于2023年发表于《美国皮肤病学会杂志》的一项研究，该研究标题为《古塞库单抗(Guselkumab)诱导治疗对轻度银屑病患者展现持久疗效：一项随机、安慰剂对照探索性临床试验结果》。